EWSR1 and neoplasm: Re-differentiated EWS-iPS maintained tumor formation competency in vivo giving rise to tumors with characteristic Ewing histopathology and demonstrated recovery of drug sensitivity upon re-differentiation in vitro, thus reiterating the pathophysiological features of the initial cell line.